Etiopathogenesis And Classification

Pyogenic Liver Abscess

  • Uncommon in healthy children; carries high mortality risk.
  • Incidence higher in developing nations and immunocompromised states (chronic granulomatous disease, hyper-immunoglobulin E syndrome).
  • Routes of hepatic invasion:
    • Portal vein: Intra-abdominal sepsis, appendicitis, omphalitis, umbilical venous catheterization.
    • Biliary tree: Cholangitis, choledochal cyst, biliary stricture, calculus.
    • Hepatic artery: Systemic sepsis, endocarditis, osteomyelitis, bacteremia.
    • Contiguous extension: Gallbladder, perinephric infections.
    • Direct inoculation: Penetrating trauma.
    • Cryptogenic: Unknown source.

Amebic Liver Abscess

  • Most common extraintestinal manifestation of Entamoeba histolytica.
  • Trophozoites invade colonic mucosa, reaching liver via portal circulation.

Microbiological Profile

Abscess TypeCommon PathogensClinical Context
Pyogenic (Developed Nations)Staphylococcus aureusMost common; strongly associated with chronic granulomatous disease.
Pyogenic (Developing Nations)Escherichia coli, Klebsiella pneumoniaeMost common gram-negative aerobes.
Pyogenic (Immunocompromised)Serratia species, Aspergillus speciesChronic granulomatous disease.
Pyogenic (Mixed)Anaerobes, Streptococcus, EnterobacterPolymicrobial infections common; secondary to biliary/portal sepsis.
AmebicEntamoeba histolyticaEndemic areas, travel history; presentation delays of months to years possible.

Clinical Manifestations

SystemSigns And Symptoms
GeneralFever, chills, malaise, fatigue, anorexia, weight loss.
AbdominalRight upper quadrant pain, tender hepatomegaly. Jaundice remains uncommon.
Specific To AmebicRight shoulder radiation. Epigastric/left shoulder pain in left lobe disease. Concurrent dysentery (10%). Localized swelling.
ComplicationsSpontaneous rupture into peritoneum, pericardium, pleura, bronchial tree. Metastatic spread to lungs/brain.

Diagnostic Evaluation

ModalityFindings And Utility
LaboratoryLeukocytosis, elevated erythrocyte sedimentation rate, hypoalbuminemia. Mildly elevated transaminases and alkaline phosphatase.
UltrasonographyFirst-line modality. Evaluates size, number, rim thickness, liquefaction. Amebic displays hypoechoic mass with surrounding rim.
Computed TomographyRequired for complicated cases. Defines extent, localizes multiple lesions, detects gas bubbles.
Chest RadiographElevated right hemidiaphragm, right pleural effusion, basilar atelectasis.
MicrobiologyBlood cultures positive in 25-35% of pyogenic cases. Pus aspiration confirms diagnosis.
Amebic AssaysSerum enzyme-linked immunosorbent assay positive in >95%. Stool polymerase chain reaction highly sensitive/specific. Aspirate yields “anchovy sauce” pus.

Management Protocol

Pyogenic Liver Abscess

  • Pharmacotherapy: Initiate broad-spectrum intravenous antibiotics (piperacillin-tazobactam, ampicillin-sulbactam, or third-generation cephalosporin plus metronidazole or clindamycin). Adjust based on culture sensitivities. Duration 4-6 weeks (initial 2 weeks parenteral).
  • Percutaneous Drainage: Ultrasound or computed tomography-guided needle aspiration/catheter drainage indicated for large abscesses (>5-7 cm), impending rupture (rim <1 cm), or failure to improve after 3-5 days of antibiotics.
  • Surgical Intervention: Reserved for multiseptate/loculated abscesses failing percutaneous drainage, frank intraperitoneal rupture, biliary obstruction, or highly viscous pus.

Amebic Liver Abscess

  • Pharmacotherapy: Nitroimidazole (metronidazole 30-50 mg/kg/day or tinidazole) for 7-10 days. Alternatively, dehydroemetine for 2 weeks.
  • Luminal Eradication: Administer luminal amebicide (paromomycin, diloxanide furoate, or iodoquinol) for 7 days to eliminate colonic cysts and prevent transmission.
  • Refractory Cases: Add daily chloroquine for 2-3 weeks for synergistic effect and enhanced abscess wall penetration.
  • Aspiration: Indicated for large abscesses (>5-7 cm), failure of medical therapy, or imminent rupture risk (especially pericardial/left lobe).